Catalyst Wire Dossier Catalyst Wire Dossier

Beriplex P/N

prothrombin complex concentrate · CSL Behring
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Beriplex P/N, covering 2023-03-08 to 2023-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk. [Phase 3]

See pricing